Stockreport

Novo Nordisk protects US patients with legal wins against compounders, including ruling that permanently prohibits compounding pharmacy from selling illegitimate, knockoff Wegovy® or Ozemp...

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF ends the grace period for pharmacies to make or sell compounded "versions" of these medicines Separate federal court ruling permanently bars MediOak Pharmacy LLC from [Read more]